Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 26, 2022 at 05:06 am EDT
Share
Jiangsu Apon Medical Technology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 72.79 million compared to CNY 102.32 million a year ago. Revenue was CNY 72.79 million compared to CNY 102.32 million a year ago. Net loss was CNY 10.99 million compared to net income of CNY 19.26 million a year ago. Basic loss per share from continuing operations was CNY 0.0872 compared to basic earnings per share from continuing operations of CNY 0.1528 a year ago. Diluted loss per share from continuing operations was CNY 0.0872 compared to diluted earnings per share from continuing operations of CNY 0.1528 a year ago.
Jiangsu Apon Medical Technology Co., Ltd. is a China-based company which is mainly engaged in research, development, production and sales of medical device products for pain management and nasal care. The Company's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The Company operates primarily in domestic and overseas markets.
JIANGSU APON MEDICAL TECHNOLOGY CO., LTD. 
